Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens an...
Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
About this item
Full title
Author / Creator
Yan, Ting , Zhu, Lingfeng and Chen, Jin
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The past decade has witnessed ongoing progress in immune therapy to ameliorate human health. As an emerging technique, chimeric antigen receptor (CAR) T-cell therapy has the advantages of specific killing of cancer cells, a high remission rate of cancer-induced symptoms, rapid tumor eradication, and long-lasting tumor immunity, opening a new window...
Alternative Titles
Full title
Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b8204c76fa554bb2a5d495b36830bf27
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b8204c76fa554bb2a5d495b36830bf27
Other Identifiers
ISSN
2162-3619
E-ISSN
2162-3619
DOI
10.1186/s40164-023-00373-7
